Journals / Retina-Vitreus / 2008 / Cilt: 16 - Sayı: 2

Complications of diabetic retinopathy therapy

Diyabetik retinopati tedavisinin komplikasyonları

Pages
95–100
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After vitreoretinal surgery vitreus haemor- rhage or re-bleeding, elevated intraocular pressure, cata- ract progression or formation, endophthalmitis or anterior hyaloidal fibrovascular proliferation can be seen.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Grid and panretinal photocoagulation, intravitreal drug in- jection and vitreoretinal surgery were the main therapeutic methods in the treatment of diabetic retinopathy.
📊
Key Findings & Data:The main reasons for therapies complications were the high energy levels used for laser photocoagulations and localisation failures.
💡
Conclusion & Impact:After vitreoretinal surgery vitreus haemor- rhage or re-bleeding, elevated intraocular pressure, cata- ract progression or formation, endophthalmitis or anterior hyaloidal fibrovascular proliferation can be seen.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Işık koagülasyonu · Ameliyat sonrası komplikasyonlar · Vitreoretinal cerrahi

Abstract

Grid and panretinal photocoagulation, intravitreal drug in- jection and vitreoretinal surgery were the main therapeutic methods in the treatment of diabetic retinopathy. The main reasons for therapies complications were the high energy levels used for laser photocoagulations and localisation failures. The high energy levels can also lead to burns of the corneal ephitelium, lens and iris. Epiretinal membrane formation, intraocular pressure rise, macular edema, vi- sual field defect, macula and optic disc damage, choroidal detachment, choroidal neovascular membrane formation and vitreus haemorrhage can occur as complications af- ter laser photocogulation. Intravitreal drug injection can lead to conjunctival haemorrhage, lens or retina damage and also to elevated intraocular pressure levels and en- dophthalmitis. After vitreoretinal surgery vitreus haemor- rhage or re-bleeding, elevated intraocular pressure, cata- ract progression or formation, endophthalmitis or anterior hyaloidal fibrovascular proliferation can be seen.

Özet

Diyabetik retinopatinin tedavisinde başvurulan yöntemler grid fotokoagulasyonu, panretinal fotokoagulasyon, intra- vitreal ilaç enjeksiyonları ve vitreoretinal cerrahidir. Fotoko- agulasyon ile ilgili olarak en sık karşılaşılan komplikasyon- lar yüksek enerji ile yapılan uygulamalara ve lokalizasyon hatalarına bağlıdır. Eksesif fotokoagulasyon kornea, lens ve iris yanıklarına neden olabilir. Bunun yanı sıra epiretinal membran oluşumu, göz içi basıncı artışı, makula ödemi, görme alanı defekti, makula veya optik disk hasarı, koroid dekolmanı, koroidal neovasküler membran, vitreus hemo- rajisi oluşumu gibi komplikasyonlar lazer fotokoagulasyon uygulamasının istenmeyen sonuçları olarak karşımıza çı- kabilir. İntravitreal enjeksiyonlarda konjonktiva hemorajisi, lens ve retina hasarı, göziçi basıncı artışı yanısıra endoftal- mi önemli bir komplikasyondur. Vitreoretinal cerrahi son- rası persistan veya tekraralayan vitreus hemorajisi, retina dekolmanı, göz içi basıncı artışı, katarakt, endoftalmi ve ön hyaloidal fibrovasküler proliferasyon gibi komplikasyonlar karşımıza çıkabilir.

🔖

Cite This Article

OVALI, T. (2008). Complications of diabetic retinopathy therapy. Retina-Vitreus, Cilt: 16 - Sayı: 2, 95–100. https://ajindex.com/articles/305196

References (17)

  1. PolIack A, Heriot WJ, Herkind P CelIular processes causing defects in,: Bruch’s membrane following krypton laser photocoagulation, Ophthalmo- logy. 1986;93:1113-1119
  2. Varley MP Frank E, PurnelI EW.: Subretinal neovascularisation after focal argon laser for diabetic macular edema, Ophthalmology. 1988;95:567- 573
  3. Ruben ST.: Corneal sensation in insulin dependent and non-insulin de- pendent diabetics with proliferative retinopathy, Acta Ophthalmol Copenh. 1994;72:576-580
  4. Lobes LAJR, Bourgon P.: Pupillary abnormalities induced by argon laser photocoagulation, Ophthalmology. 1985;92:234-236
  5. Lerner BC, Lakhanpal V, Schocket SS.: Treatment myopia and accommo- dative paresis following cryotherapy and panretinal photocoagulation, Am J Ophthalmol. 1984;97:704-708
  6. Braun CI, Benson WE, Remaley NA et al.: Accommodative amplitudes in the Early Treatment Diabetic Retinopathy Study, Retina. 1995;15:275- 281
  7. Gass JDM.: Complications of photocoagulation therapy of macular lesi- ons. In: Craven D, ed, Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment (Mosby: St Louis, 1997)
  8. Olk LJ, Lee CM.: Complications and side effects of treatment. In: Papado- paulos D, ed, Diabetic Retinopathy. Practical Management (JB Lippencott: Philadelphia, 1993)
  9. McCanna R, Chandra SR, Stevens TS et al.: Argon laser-induced cata- ract as a complication of retinal photocoagulation, Arch Ophthalmol. 1982;100:1071-1073
  10. Bondeau P Pavan PR, Phelps CD.: Acute pressure elevation following pan- retinal photocoagulation, Am J Ophthalmol. 1981;99:1239-1242
  11. Mensher JH, Anterior chamber depth alteration after retinal photocoagula- tion, Arch Ophthalmol. 1977;95:113-116
  12. Boulton PE.: A study of the mechanism of transient myopia following ex- tensive xenon arc photocoagulation, Trans Ophthalmol Soc UK. 1974;93: 287-300
  13. Huamonte FU, Peyman GA, Goldberg MF, et al.: Immediate fundus comp- lications after retinal scatter photocoagulation. I. Clinical picture and pat- hogenesis, Ophthalmol Surg. 1976;7:88-99
  14. Phelps C.: Angle closure glaucoma secondary to ciliary body swelling, Arch Ophthalmol. 1974;92:286-290
  15. Doft BH, Blankenship GW.: Single versus multiple treatment sessions of argon laser photocoagulation for proliferative diabetic retinopathy, Oph- thalmology. 1982;89:772-790
  16. Ferris FL, Podger MJ, Davis MD.: The Diabetic Retinopathy Study Research Group, Report no
  17. Macular edema in diabetic retinopathy study pati- ents, Ophthalmol